Centre Hospitalier Universitaire De Nantes
Verified
Nantes, France
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
This study involves patients who need to have a breathing tube placed in their windpipe during surgery and who have at least one risk factor for stomach contents moving back up into the throat, which could cause serious breathing problems. The study will compare three different medications used to make patients unconscious before placing the breathing tube: remimazolam, propofol, and ketamine. All three medications will be given through a vein as an injection. The purpose of the study is to compare how well remimazolam works compared to standard doses of propofol and ketamine in allowing the breathing tube to be successfully placed on the first try in patients at risk of stomach contents moving up into the throat.
During the study, patients will receive one of the three medications to make them unconscious before the breathing tube is placed. The medical team will measure how successfully the breathing tube can be placed on the first attempt, which is the main goal of the study. They will also look at several other things during and after the procedure, including how easy it is to place the breathing tube, how long it takes to complete different steps of the process, and measurements of heart rate, blood pressure, and oxygen levels in the blood during the first five minutes after the medication is given. The team will check for any problems such as stomach contents moving into the lungs, low oxygen levels, changes in blood pressure or heart rate that require treatment, allergic reactions, and whether additional medications or fluids are needed.
After the procedure, patients will be monitored in the recovery room where the medical team will check for confusion or agitation and whether any calming medication is needed. For up to seven days after surgery, the study will track whether patients develop heart problems, kidney problems, or other serious complications, as well as survival rates. The study will help doctors understand whether remimazolam is as safe and effective as the other two medications currently used for this type of procedure.
The trial runs in 9 steps – from screening to follow-up. Each step says what happens and what the team monitors.
8 criteria
1 criterion
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Nantes, France
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not yet recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
is a sedative medication that helps put patients to sleep before medical procedures. In this study, it is being tested to see how well it works for helping doctors insert a breathing tube into the windpipe.
is an anesthetic medication used to make patients unconscious for surgery or procedures. It works quickly and is commonly used when doctors need to insert a breathing tube rapidly.
is a sedative medication that puts patients to sleep for surgery or medical procedures. It acts very quickly and is widely used to help patients become unconscious before a breathing tube is inserted.
Remimazolam is a short-acting sedative medication given through an intravenous injection (into a vein) and is used to put patients to sleep before surgery or medical procedures. It belongs to a class of drugs called benzodiazepines, which work by enhancing the calming effects of a natural chemical in the brain called GABA, helping to reduce brain activity and induce sleep quickly. This medication is particularly useful for rapid sequence induction, a technique used when patients need to be put to sleep very quickly to protect their airway, especially when there is a risk of stomach contents entering the lungs. Remimazolam is currently being studied in clinical trials and is approved in some countries as an alternative to other anesthetic agents because it works fast and wears off quickly after the procedure is finished.
Ketamine is an anesthetic medication that can be given through injection into a vein or muscle, and it is used to induce sleep and provide pain relief during surgical procedures. It works differently from most anesthetics by blocking a specific receptor in the brain called the NMDA receptor, which helps produce a dissociative state where patients feel detached from their surroundings and experience reduced pain sensation. This medication is widely used in emergency and operating room settings, particularly for rapid sequence induction when patients need quick airway protection, because it maintains breathing reflexes and blood pressure better than some other anesthetics. Ketamine has been used in medical practice for many decades and is considered a safe and effective option, especially in patients who may be at risk for low blood pressure during anesthesia.
Propofol is a widely used anesthetic medication administered through intravenous injection (into a vein) to induce and maintain sleep during surgical procedures and medical interventions. It belongs to a class of medications called sedative-hypnotics and works by enhancing the activity of GABA, a natural brain chemical that slows down nerve signals, resulting in rapid loss of consciousness and sedation. This medication is the most commonly used agent for rapid sequence induction in operating rooms because it acts very quickly, typically putting patients to sleep within seconds, and wears off rapidly when the infusion is stopped. Propofol has been a standard medication in anesthesia practice for over three decades and is valued for its predictable effects and smooth recovery profile.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.